2S3-13110-39988
5 vaccinations
16 coded responses
61 check-ins
16 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 152 / PA
- Registered
- 2021-01-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Dose 1 — Pfizer-BioNTech
-
2021-01-17
Registered in v-safe
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-18
- 2021-01-22
- 2021-01-23
- 2021-01-30
-
2021-02-06
Dose 2 — Pfizer-BioNTech
- 2021-02-06
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, NauseaAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Joint pains, Nausea, DiarrheaAdult check-in
-
2021-02-09
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Sore throat from nasal drainageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Paranasal sinus hypersecretion — Feeling: GoodFree text: Sore throat from nasal drainage.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Upper-airway cough syndrome — Feeling: GoodFree text: Mild sore throat due to drainageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
-
2021-02-13
Survey response — day 7, dose 2MedDRA: Oropharyngeal pain, Upper-airway cough syndrome — Feeling: Good · HeadacheFree text: Mild sore throat due to sinus drainage.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Survey response — day 14, dose 2MedDRA: Headache, Vision blurred — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Headache and blurred vision.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Survey response — day 21, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sore, enlarged, tender submandibular lymph node on same side as injection for 3-4 days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-06
Survey response — day 28, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: GoodFree text: Environmental Allergies and asthma flare.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-13
-
2021-03-20
Survey response — day 42, dose 2MedDRA: Asthma, Pre-existing disease, Specialist consultation — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Asthma flare. For the last 3 weeks. Usually no asthma symtoms this time of year and no asthma medications. Now on 3 medications. Very unusual. Asthma doctor thinks it is related to cytokynic storm from vaccine second shot. · Healthcare visit (other): Regular in person visit with asthma and allergy specialistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-08
- 2021-07-31
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: Fair · Fatigue or tirednessFree text: Sore throat yesterday and today.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Mild sire throatMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Slight sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Slight sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Minor sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-31
- 2021-11-05
- 2021-11-12
- 2021-12-31
- 2022-04-01
-
2022-04-22
Dose 4 — Pfizer-BioNTech
- 2022-04-22
- 2022-04-23
-
2022-04-24
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-04-25
- 2022-04-26
- 2022-04-27
- 2022-04-28
- 2022-05-01
- 2022-05-06
- 2022-05-13
- 2022-05-22
- 2022-05-27
-
2022-06-03
Survey response — day 42, dose 4MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throat.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Survey response — 3 months, dose 4MedDRA: Cough, Fatigue, Nasal congestion, Oropharyngeal pain, Productive cough, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Runny nose and nasal congestion. Sore throat. Dry intermittent cough becoming more productive. Tired. No fever. Negative home COVID antigen test.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-25
- 2022-07-25
- 2022-07-25
-
2022-07-26
Call successfulNot applicable - Accidental Reporting
-
2022-07-26
Call successfulNot applicable - Accidental Reporting
-
2022-07-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-22
Survey response — 6 months, dose 4MedDRA: Headache, Nasal congestion, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Body aches, headache, nasal congestion,fever.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-25
-
2023-01-05
Dose 5 — Pfizer-BioNTech
-
2023-01-07
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2023-01-08
- 2023-01-09
- 2023-01-10
- 2023-01-11
- 2023-01-12
- 2023-01-19
- 2023-01-26
- 2023-02-02
- 2023-02-09
- 2023-02-16
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-06 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-04-22 | Pfizer-BioNTech | No |
| 5 | 2023-01-05 | Pfizer-BioNTech | No |
Call center
5 call center cases
3 successful · 1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
2 waits over 3 months for a first call
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat from nasal drainage
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat from nasal drainage.
Systemic reaction (other): Mild sore throat due to drainage
Release 4 — day 7, dose 2
Systemic reaction (other): Mild sore throat due to sinus drainage.
Release 4 — day 14, dose 2
Symptoms: Headache and blurred vision.
Release 4 — day 21, dose 2
Symptoms: Sore, enlarged, tender submandibular lymph node on same side as injection for 3-4 days.
Release 5 — day 28, dose 2
Symptoms: Environmental Allergies and asthma flare.
Release 6 — day 42, dose 2
Symptoms: Asthma flare. For the last 3 weeks. Usually no asthma symtoms this time of year and no asthma medications. Now on 3 medications. Very unusual. Asthma doctor thinks it is related to cytokynic storm from vaccine second shot.
Healthcare visit (other): Regular in person visit with asthma and allergy specialist
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat yesterday and today.
Systemic reaction (other): Mild sire throat
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Slight sore throat
Systemic reaction (other): Slight sore throat
Systemic reaction (other): Minor sore throat
Release 11 — day 42, dose 4
Symptoms: Sore throat.
Release 12 — 3 months, dose 4
Symptoms: Runny nose and nasal congestion. Sore throat. Dry intermittent cough becoming more productive. Tired. No fever. Negative home COVID antigen test.
Release 12 — 6 months, dose 4
Symptoms: Body aches, headache, nasal congestion,fever.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Asthma | ✓ | ✓ | ✓ |
| HCVO | Specialist consultation | ✓ | ✓ | ✓ |
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lymph node pain | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Paranasal sinus hypersecretion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release